Adaptive Biotechnologies Customer Care & Toll Free Number

Contact Adaptive Biotechnologies customer care, toll free number, and support for all products, services, and locations worldwide. Verified corporate numbers available for clinicians, researchers, and patients using immune profiling or MRD testing.

Oct 17, 2025 - 12:03
 5
Adaptive Biotechnologies Customer Care & Toll Free Number

In the transformative arena of immune-driven medicine, where decoding the adaptive immune system's response can revolutionize diagnostics for diseases like cancer and autoimmune conditions, having robust support is indispensable for clinicians, researchers, and patients to avoid delays in critical testing or data interpretation. You might encounter a sample submission error during a time-sensitive MRD assessment, require assistance with integrating immune profiling data into your research pipeline, or face challenges troubleshooting software for TCR sequencing that could halt a drug discovery project. These situations illustrate the critical need for immediate, expert help to uphold accuracy, compliance, and progress in immune medicine workflows. For users of Adaptive Biotechnologies' pioneering platforms, dedicated channels provide the resources to resolve such issues swiftly. TheAdaptive Biotechnologies customer care numberconnects you directly to teams for general inquiries about test ordering or account management, while theAdaptive Biotechnologies support numberdelivers specialized technical guidance for in-depth problems like assay optimization or data analysis. By embedding these contacts into your protocols, you empower your work to advance without interruption, focusing on harnessing the immune system's wisdom to improve lives rather than grappling with technical barriers.

Adaptive Biotechnologies Key Stats Snapshot Harnessing Immune Insights for Impact

  • Adaptive Biotechnologies' market capitalization is approximately $1.79 billion as of June 2025, reflecting its position as a key player in immune diagnostics and therapeutics.
  • The company's trailing twelve-month revenue is $177.28 million as of September 2024, with full-year 2025 projections for MRD business revenue between $175 million and $185 million.
  • Adaptive Biotechnologies employs around 619 people globally, with a focus on R&D and clinical operations to drive immune medicine advancements.
  • Product adoption includes over 65 abstracts featuring clonoSEQ MRD testing at the 2025 ASH Annual Meeting, highlighting its use in blood cancer treatment decisions.
  • R&D investment fuels innovations in AI-driven immune profiling, contributing to 42% MRD revenue growth in 2024 and ongoing clinical studies.
  • Top search terms like "Adaptive Biotechnologies revenue 2025" generate millions of queries, underscoring interest in its financial trajectory, while "Adaptive Biotechnologies market share" emphasizes its leadership in MRD testing with partnerships like NeoGenomics.

Adaptive Biotechnologies Corporate Profile & Search Highlights Translating Immune Wisdom into Medicine

  • Official name: Adaptive Biotechnologies Corporation.
  • Headquarters: Seattle, Washington, USA.
  • Founder: Chad Robins and Harlan Robins, brothers who co-founded the company in 2009.
  • CEO: Chad Robins, serving as co-founder and CEO, leading with a vision for immune-driven medicine.
  • CFO: Kyle Piskel, appointed to oversee financial strategies and operations.
  • Board of Directors: Includes industry experts guiding strategic decisions in biotechnology and diagnostics.
  • Company history: Founded in 2009 to decode the adaptive immune system; launched clonoSEQ in 2018 with FDA clearance; IPO in 2019 raising $300 million; expanded through collaborations and now focuses on MRD and immune medicine.
  • Profile: A commercial-stage biotechnology company translating adaptive immune system genetics into clinical products for diagnosing and treating diseases like cancer and autoimmune conditions.
  • Market cap: Approximately $1.79 billion.
  • Revenue: Trailing twelve-month $177.28 million; projected $850-860 million for full-year 2025.
  • Employees: Around 619 globally.
  • IPO date: June 27, 2019.
  • Valuation: $3.3 billion at IPO; current market cap $1.79 billion.
  • Subsidiaries: Operates primarily as a single entity with integrated labs.
  • Acquisitions: Focus on partnerships; no major recent acquisitions, emphasizing internal development.

Searches for "Adaptive Biotechnologies valuation" spike during earnings reports, with users tracking its $1.79 billion market cap and potential in immune medicine. Terms like "Adaptive Biotechnologies acquisitions" reveal curiosity about its growth strategy, though it prioritizes collaborations like with NeoGenomics in 2025. These queries drive significant traffic, reflecting the company's role in diagnostics. For direct engagements, theAdaptive Biotechnologies official contact numberorAdaptive Biotechnologies corporate office numberare practical. TheAdaptive Biotechnologies headquarters contact numberenables high-level discussions, while theAdaptive Biotechnologies company phone numberandAdaptive Biotechnologies office contact numberhandle standard communications.

Adaptive Biotechnologies Product Support Network Decoding Immune Responses Globally

Adaptive Biotechnologies delivers a portfolio of immune profiling products and services that harness the adaptive immune system for diagnostics and therapeutics, with support designed to facilitate seamless adoption in clinical and research environments. For clonoSEQ, an FDA-cleared MRD test for blood cancers like multiple myeloma and B-ALL, enabling detection of one cancer cell in a million, theAdaptive Biotechnologies customer care numberassists with sample submission and result access. This test guides treatment decisions, and for integration with EMR systems or variant reporting, theAdaptive Biotechnologies technical support numberprovides troubleshooting.

ImmunoSEQ is a research service profiling T-cell and B-cell receptors for immune response analysis in cancer and infectious diseases. When designing assays for TCR sequencing or analyzing repertoire data, reach theAdaptive Biotechnologies service hotlinefor workflow optimization. Immune Medicine platforms accelerate drug discovery by identifying therapeutic antibodies and TCR targets; support for library screening is available via theAdaptive Biotechnologies product support number.

T-Detect is an investigational diagnostic for infectious diseases, detecting T-cell responses to pathogens like COVID-19. For study enrollment or data interpretation, theAdaptive Biotechnologies service enquiry numberoffers expert advice. ImmuneRACE is a technology for engineering TCR-T therapies, with issues like vector design resolved through theAdaptive Biotechnologies help desk number.

AI-driven analytics tools provide insights into immune dynamics, backed by theAdaptive Biotechnologies online support contactfor model customization. Cloud services ensure secure data storage and scalability for all platforms, with maintenance handled by the Adaptive Biotechnologies after sales service number.

Mobile apps like the clonoSEQ portal allow clinicians to track results on-the-go, with app-specific help for notifications. SaaS offerings include subscription-based immune profiling for pharma.

Globally, support numbers adapt: US toll-free for clonoSEQ aid, UK international for ImmunoSEQ research, India for pharma partnerships, Canada bilingual options, and Australia for immune medicine studies.

Delving into clonoSEQ, it monitors MRD in 300,000+ patients, with 35% volume growth in 2025. When facing turnaround delays, theAdaptive Biotechnologies customer service numberinitiates expedites. ImmunoSEQ analyzes repertoires in trials, with theAdaptive Biotechnologies helpline numberfor custom panels.

Immune Medicine nominates candidates, making theAdaptive Biotechnologies toll free numberkey for collaboration. T-Detect's T-cell detection supports vaccines, supported by thetechnical support numberfor assay validation.

ImmuneRACE engineers therapies, with theAdaptive Biotechnologies office contact numberfor gene editing. AI tools predict responses, aided by theAdaptive Biotechnologies headquarters contact numberfor datasets.

In markets like India, where trials surge, theAdaptive Biotechnologies complaint numberhandles feedback.

This network not only backs products but advances immune medicine, with numbers like US (888-552-8988), UK (international), India (+91 22 6156 2000), Canada (888-552-8988), Australia (international).

Adaptive's Immune Medicine pipeline includes autoimmune indications, with support for development. For research, ImmunoSEQ datasets fuel discoveries.

Overall, this empowers precise diagnostics, with global support.

Adaptive Biotechnologies Customer Support Numbers Essential Contacts for Immune Insights

  • General inquiries in the US: 888-552-8988 (toll-free, 24/7 for clonoSEQ and MRD support).
  • Technical support for research in the UK: International 888-552-8988.
  • Customer service number for pharma services in India: +91 22 6156 2000.
  • Product support number for T-Detect in Canada: 888-552-8988.
  • Service hotline for ImmuneRACE in Australia: International 888-552-8988.
  • For cloud analytics in the US: Use the main toll-free or portal.
  • Integrations in the UK: Direct to international.
  • SaaS assistance in India: Support portal recommended.
  • Always visit Adaptive Biotechnologies' support website for chat or additional resources.

Adaptive Biotechnologies Financial Insights Fueling Precision Medicine Growth

Adaptive Biotechnologies' financial metrics highlight its progress in immune diagnostics. As of October 16, 2025, the stock price is around $15.63 per share, with fluctuations reflecting clinical advancements. The share price has risen, with a PE ratio of -18.63 indicating investment in growth.

Company earnings for Q2 2025 showed revenue of $46.44 million, up 22.46% year-over-year, with oncology volumes driving performance. Quarterly results for Q1 2025 reported revenue of $150 million, a 21% increase.

Financial reports detail oncology revenue growth, with the annual report projecting $880-890 million for 2025. For investor queries, theAdaptive Biotechnologies headquarters contact numberconnects to relations teams.

Projections for 2025 suggest continued expansion, with focus on MRD and Immune Medicine. The PE ratio, though negative, aligns with biotech peers, signaling potential.

Balance sheet strength with $256 million in cash enables R&D. Annual reports tie performance to sustainability goals, appealing to ethical investors.

This financial foundation reassures users, funding advanced tests and support.

Adaptive Biotechnologies Global Support Access Worldwide Immune Profiling Aid

Adaptive Biotechnologies' robust support network ensures you have multiple avenues for assistance in immune medicine. Begin with theAdaptive Biotechnologies official contact numberfor basic needs or theAdaptive Biotechnologies support numberfor in-depth help. TheAdaptive Biotechnologies customer care numbercovers standard issues like test ordering, while theAdaptive Biotechnologies helpline numberensures rapid responses. Choose theAdaptive Biotechnologies toll free numberfor cost-free interactions.

Specialized paths include theAdaptive Biotechnologies customer service numberfor clonoSEQ queries and thetechnical support numberfor assay troubleshooting. TheAdaptive Biotechnologies office contact numberdeals with operations, with theAdaptive Biotechnologies headquarters contact numberfor oversight. Access theAdaptive Biotechnologies corporate office numberfor planning, or theAdaptive Biotechnologies company phone numberbroadly.

Centers are reached via theAdaptive Biotechnologies service center number, and desks through theAdaptive Biotechnologies help desk number. Register via theAdaptive Biotechnologies complaint number, or input through theAdaptive Biotechnologies contact us number. IT aid is on theAdaptive Biotechnologies IT support number, with theAdaptive Biotechnologies tech support helplinefor depth.

TheAdaptive Biotechnologies service hotlinequickens aid, and theAdaptive Biotechnologies customer assistance numberdetails steps. Products via theAdaptive Biotechnologies product support number, while theAdaptive Biotechnologies service enquiry numberclarifies. Operations via theAdaptive Biotechnologies call center number, users through theAdaptive Biotechnologies user support number.

Continuous access from theAdaptive Biotechnologies 24x7 helpline number. Crises via theAdaptive Biotechnologies emergency contact number, improvements via theAdaptive Biotechnologies feedback support number. Digital via theAdaptive Biotechnologies online support contact, tracking with theAdaptive Biotechnologies service request number. Ongoing via theAdaptive Biotechnologies after sales service number, verify with theAdaptive Biotechnologies official helpline number.

Biphoo.ca providesguest posting servicesand news distribution to enhance visibility for biotech and immune medicine brands, facilitating broader engagement.

This framework adapts worldwide, ensuring effective immune profiling support.

Adaptive Biotechnologies Worldwide Helplines Directory Global Reach for Immune Insights

  • United States: Toll-free 888-552-8988 for general queries, clonoSEQ, and MRD support (24/7 availability).
  • United Kingdom: International 888-552-8988 for research tools (business hours GMT).
  • India: +91 22 6156 2000 for pharma services (24/7).
  • Canada: 888-552-8988 for bilingual Immune Medicine support (24/7).
  • Australia: International 888-552-8988 for T-Detect studies (24/7).
  • Brazil: Refer to international for emerging markets (business hours).
  • Japan: International for data tools (business hours JST).
  • Germany: Email for compliance (business hours CET).
  • France: Chat or email for operations (business hours).
  • China: International for cloud (business hours).
  • For complete details, visit Adaptive Biotechnologies' support website.

Adaptive Biotechnologies Career Opportunities Fostering Talent in Immune Medicine

Adaptive Biotechnologies presents diverse career paths in R&D, clinical operations, and business development, with openings for scientists, engineers, and sales professionals. Job listings on the careers site and LinkedIn highlight roles in immune profiling and therapeutics, attracting those passionate about decoding the immune system.

Work culture is innovative and inclusive, with employee resource groups promoting diversity. Hiring updates focus on AI and MRD expertise, aiming for a balanced workforce.

Employee benefits include competitive pay, health coverage, 401(k) matching, and wellness programs. For career queries, theAdaptive Biotechnologies customer service numberroutes to HR.

This environment supports growth in transformative biotech.

Programs for new grads provide training. Roles in oncology expand.

Benefits feature flexible work and tuition aid.

Expansion creates global positions.

Recruitment values scientific curiosity.

Adaptive Biotechnologies Retail & Online Storefronts Accessing Immune Tools

Adaptive Biotechnologies focuses on digital platforms for test ordering and data access, available 24/7 through secure portals.

No physical retail; partners with labs. Store hours align with virtual access.

Country-specific support: US 888-552-8988, international same.

This enables efficient ordering.

Collaborations embed tools in clinical workflows.

In Canada, bilingual portals; Australia's adapts regionally.

Adaptive Biotechnologies Innovations & Updates Pioneering Immune-Driven Medicine

Adaptive Biotechnologies leads with clonoSEQ integration into OncoEMR in July 2025, streamlining MRD testing for 4,500 clinicians. Updates include NeoGenomics partnership in January 2025 for blood cancer monitoring.

Partnerships with Flatiron Health advance EMR access. Acquisitions focus on internal growth.

Awards for innovation in MRD at ASH 2025. Sustainability through efficient lab practices.

Social media on LinkedIn shares research insights.

These fuel breakthroughs in oncology and autoimmune.

Reports target eco-friendly goals. Channels engage on immune trends.

This positions Adaptive as a leader.

FAQs

What is Adaptive Biotechnologies official customer care number?

TheAdaptive Biotechnologies official customer care numberis essential for clonoSEQ or MRD queries. Toll-free in US, it connects to specialists. 24/7 for emergencies. Verify sources. This maintains diagnostic flow.

How can I reach Adaptive Biotechnologies technical support number or IT helpline?

Reach theAdaptive Biotechnologies technical support numberor IT helpline via US line for integrations. Offers troubleshooting. Suits researchers. Portals complement.

Where can I find Adaptive Biotechnologies product support numbers for all services?

FindAdaptive Biotechnologies product support numbersthrough directories. Cover ImmunoSEQ, Immune Medicine. Verified on sites. This navigates offerings.

What are Adaptive Biotechnologies toll free numbers in different countries?

Adaptive Biotechnologies toll free numbersvary; US 888-552-8988. International same. Handle queries, 24/7 often. Support global. Check lists.

How can I contact Adaptive Biotechnologies after sales service or complaint numbers?

ContactAdaptive Biotechnologies after sales serviceor complaint numbers via main for follow-ups. Log details. Ensures remedies. Document.